Literature DB >> 18434651

Mutations in the iodotyrosine deiodinase gene and hypothyroidism.

José C Moreno1, Willem Klootwijk, Hans van Toor, Graziella Pinto, Mariella D'Alessandro, Aubène Lèger, David Goudie, Michel Polak, Annette Grüters, Theo J Visser.   

Abstract

DEHAL1 has been identified as the gene encoding iodotyrosine deiodinase in the thyroid, where it controls the reuse of iodide for thyroid hormone synthesis. We screened patients with hypothyroidism who had features suggestive of an iodotyrosine deiodinase defect for mutations in DEHAL1. Two missense mutations and a deletion of three base pairs were identified in four patients from three unrelated families; all the patients had a dramatic reduction of in vitro activity of iodotyrosine deiodinase. Patients had severe goitrous hypothyroidism, which was evident in infancy and childhood. Two patients had cognitive deficits due to late diagnosis and treatment. Thus, mutations in DEHAL1 led to a deficiency in iodotyrosine deiodinase in these patients. Because infants with DEHAL1 defects may have normal thyroid function at birth, they may be missed by neonatal screening programs for congenital hypothyroidism. Copyright 2008 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434651     DOI: 10.1056/NEJMoa0706819

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  46 in total

Review 1.  The distribution and mechanism of iodotyrosine deiodinase defied expectations.

Authors:  Zuodong Sun; Qi Su; Steven E Rokita
Journal:  Arch Biochem Biophys       Date:  2017-07-31       Impact factor: 4.013

2.  A switch between one- and two-electron chemistry of the human flavoprotein iodotyrosine deiodinase is controlled by substrate.

Authors:  Jimin Hu; Watchalee Chuenchor; Steven E Rokita
Journal:  J Biol Chem       Date:  2014-11-13       Impact factor: 5.157

3.  Clinical, biochemical, and molecular findings in Argentinean patients with goitrous congenital hypothyroidism.

Authors:  Ana Chiesa; Carina M Rivolta; Héctor M Targovnik; Laura Gruñeiro-Papendieck
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

4.  Adaptive divergence in the thyroid hormone signaling pathway in the stickleback radiation.

Authors:  Jun Kitano; Sean C Lema; J Adam Luckenbach; Seiichi Mori; Yui Kawagishi; Makoto Kusakabe; Penny Swanson; Catherine L Peichel
Journal:  Curr Biol       Date:  2010-11-18       Impact factor: 10.834

Review 5.  The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.

Authors:  Silvia Ravera; Andrea Reyna-Neyra; Giuseppe Ferrandino; L Mario Amzel; Nancy Carrasco
Journal:  Annu Rev Physiol       Date:  2017-02-10       Impact factor: 19.318

6.  Active Site Binding Is Not Sufficient for Reductive Deiodination by Iodotyrosine Deiodinase.

Authors:  Nattha Ingavat; Jennifer M Kavran; Zuodong Sun; Steven E Rokita
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

Review 7.  Defects of Thyroid Hormone Synthesis and Action.

Authors:  Zeina C Hannoush; Roy E Weiss
Journal:  Endocrinol Metab Clin North Am       Date:  2017-03-06       Impact factor: 4.741

8.  A mammalian reductive deiodinase has broad power to dehalogenate chlorinated and brominated substrates.

Authors:  Patrick M McTamney; Steven E Rokita
Journal:  J Am Chem Soc       Date:  2009-10-14       Impact factor: 15.419

9.  Congenital hypothyroidism caused by a novel homozygous mutation in the thyroglobulin gene.

Authors:  Patrizia Agretti; Giuseppina De Marco; Caterina Di Cosmo; Eleonora Ferrarini; Lucia Montanelli; Brunella Bagattini; Paolo Vitti; Massimo Tonacchera
Journal:  Eur J Pediatr       Date:  2013-03-03       Impact factor: 3.183

Review 10.  Congenital hypothyroidism.

Authors:  Maynika V Rastogi; Stephen H LaFranchi
Journal:  Orphanet J Rare Dis       Date:  2010-06-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.